ozgurdonmaz/E+ via Getty Images
- Vaxcyte (NASDAQ:PCVX) has priced its public offering of 2.5M shares of common stock and pre-funded warrants to purchase equal number of shares.
- The shares and pre-funded warrants are being sold at $20.00/share and $19.999/underlying share, respecrively.
- Expected gross proceeds are ~$100M.
- Underwriters' over-allotment is an additional 750K shares.
- Closing date is January 18, 2022.
- Shares down 8.3% after-hours. Yesterday's close was $22.00.
- Previously (Jan. 12): Vaxcyte launches stock offering